CODX

Co-Diagnostics, Inc.

Nasdaq · Surgical & Medical Instruments & Apparatus · Inc. UT · CIK 0001692415

$3.37 +1.20% $12.4M

High Impact Filing (7/10)

Vol

Market Cap$12.4M

Cap SizeNano Cap

Inst. Holders5 funds

Inst. Value$332.00

Reddit Sentiment50° Neutral

SEC Reports6

Exchange Nasdaq·Sector Surgical & Medical Instruments & Apparatus·Inc. UT·CIK 0001692415·Prev Close $3.33

Recent Activity

Jun 4, 2026 short_volume

Short Volume: CODX — 58.2% short (0.7M / 1.1M)

Short: 660,242 | Exempt: 202,106 | TRF Vol: 1,133,839 | Short Ratio: 58.2% | Off-exchange volume (da

Jun 1, 2026 SEC

Co-Diagnostics' universal shelf registration (File No. 333-296312) became effective on May 29, 2026, allowing the compan

EFFECT — Impact 7/10

May 23, 2026 Insider

Brown Brian Lee was granted 3,750 shares

Chief Financial Officer

May 23, 2026 Insider

Abbott Richard David was granted 1,890 shares

President

May 23, 2026 Insider

Brown Brian Lee disposed of 1,350 shares

Chief Financial Officer @ $5.07 ($6.8K)

May 21, 2026 SEC

Co-Diagnostics entered into a securities purchase agreement to raise $3M through the sale of common shares, pre-funded w

8-K — Impact 8/10

May 18, 2026 SEC

Co-Diagnostics' universal shelf registration (File No. 333-295803) became effective on May 15, 2026, enabling the compan

EFFECT — Impact 8/10

Analyst Ratings

Historical distribution0% buy · 7 analysts · last covering-analyst action Nov 2025

0Strong Buy

0Buy

4Hold

1Sell

2Strong Sell

Historical Analyst Actions

Date	Firm	Action	Rating
Nov 26, 2025	Maxim Group	INITIATE	Buy
Nov 24, 2025	HC Wainwright & Co.	REITERATE	Neutral → Neutral
Oct 28, 2025	D. Boral Capital	MAINTAIN	Buy → Buy
Oct 16, 2025	D. Boral Capital	MAINTAIN	Buy → Buy
Sep 19, 2025	D. Boral Capital	MAINTAIN	Buy → Buy

Earnings Estimates

Period	EPS Est.	Range	Growth	#
Current Q	$-3.00	$-3.00 — $-3.00	57% YoY	1
Next Q	$-3.30 ▼ -15.8%	$-3.30 — $-3.30	29% YoY	1
Current FY	$-13.50 ▼ -11.1%	$-13.50 — $-13.50		1
Next FY	$-12.00 ▼ -300.0%	$-12.00 — $-12.00	11% YoY	1

Latest Reports

BEARISH EFFECT 7/10

Co-Diagnostics' universal shelf registration (File No. 333-296312) became effective on May 29, 2026, allowing the compan

Jun 1, 2026

BEARISH 8-K 8/10

Co-Diagnostics entered into a securities purchase agreement to raise $3M through the sale of common shares, pre-funded w

May 21, 2026

Top Institutional Holders

Fund	Value	Move
MORGAN STANLEY	$164.00	—
WELLS FARGO & COMPANY/MN	$151.00	—
DANSKE BANK A/S	$13.00	—
VANGUARD FIDUCIARY TRUST CO	$2.00	—
CITIGROUP INC	$2.00	—

Recent Insider Trades

Date	Insider	Type	Value
May 23, 2026	Brown Brian	A	$0.00
May 23, 2026	Abbott Richard	A	$0.00
May 23, 2026	Brown Brian	D	$6.8K
May 23, 2026	Brown Brian	M	$0.00
May 23, 2026	SERBIN RICHARD	M	$0.00

Reddit Sentiment

50°▼

Neutral

Bearish Neutral Bullish

10 mentions 4 bullish 4 bearish

5 institutional holders with $332.00 total value (178 shares) as of 2026-Q1. Top holders: MORGAN, WELLS, DANSKE.

Top Institutional Holders — 2026-Q1

#	Fund	Shares	Value	% of Tracked	Last Move
1	MORGAN STANLEY	88	$164.00	49.4%	—
2	WELLS FARGO & COMPANY/MN	81	$151.00	45.5%	—
3	DANSKE BANK A/S	7	$13.00	3.9%	—
4	VANGUARD FIDUCIARY TRUST CO	1	$2.00	0.6%	—
5	CITIGROUP INC	1	$2.00	0.6%	—

6 unique insiders with 14 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).

Insider Transactions

Date	Insider	Title	Type	Shares	Price	Value
May 23, 2026	Brown Brian Lee	Chief Financial Officer	AWARD	3,750	—	—
May 23, 2026	Abbott Richard David	President	AWARD	1,890	—	—
May 23, 2026	Brown Brian Lee	Chief Financial Officer	D	1,350	$5.07	$6.8K
May 23, 2026	Brown Brian Lee	Chief Financial Officer	EXERCISE	3,750	—	—
May 23, 2026	SERBIN RICHARD S	Director	EXERCISE	1,695	—	—
May 23, 2026	Abbott Richard David	President	D	680	$5.07	$3.4K
May 23, 2026	Murphy Edward L.	Director	AWARD	1,695	—	—
May 23, 2026	SERBIN RICHARD S	Director	AWARD	1,695	—	—
May 23, 2026	Abbott Richard David	President	EXERCISE	1,890	—	—
May 23, 2026	Murphy Edward L.	Director	EXERCISE	1,695	—	—
May 23, 2026	Durenard Eugene	Director	AWARD	1,695	—	—
May 23, 2026	Durenard Eugene	Director	EXERCISE	1,695	—	—
May 23, 2026	NELSON JAMES B	Director	EXERCISE	1,695	—	—
May 23, 2026	NELSON JAMES B	Director	AWARD	1,695	—	—

6 SEC filing reports analyzed. Sentiment: 0 bullish, 6 bearish, 0 mixed, 0 neutral. Avg impact: 7.5/10.

BEARISH EFFECT 7/10

Co-Diagnostics' universal shelf registration (File No. 333-296312) became effective on May 29, 2026,

Jun 1, 2026

BEARISH 8-K 8/10

Co-Diagnostics entered into a securities purchase agreement to raise $3M through the sale of common

May 21, 2026

BEARISH EFFECT 8/10

Co-Diagnostics' universal shelf registration (File No. 333-295803) became effective on May 15, 2026,

May 18, 2026

BEARISH 8-K 7/10

Co-Diagnostics reported Q1 2026 revenue of $0.15M (up from $0.05M YoY) and a net loss of $9.1M ($4.0

May 14, 2026

BEARISH S-3 8/10

Co-Diagnostics filed a universal shelf registration statement to offer up to $150M in securities (co

May 12, 2026

BEARISH 8-K 7/10

Co-Diagnostics reported a significant year-over-year revenue decline from $3.9M to $0.6M in 2025, dr

Apr 21, 2026

∅

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Historical analyst distribution (last covering-analyst action Nov 2025): 0% buy across 7 analysts — 0 strong buy, 0 buy, 4 hold, 1 sell, 2 strong sell. No current recommendation available.

Earnings Estimates & Revisions

Period	EPS Avg	EPS Low	EPS High	EPS Growth	30d Rev.	Up/Down	Rev. Avg	Rev. Growth	Analysts
Current Q 2026-06-30	$-3.00	$-3.00	$-3.00	57.2%	+0.0%	0↑ 1↓	$0.0B	-18.4%	1
Next Q 2026-09-30	$-3.30	$-3.30	$-3.30	29.2%	-15.8%	1↑ 0↓	$0.0B	-0.9%	1
Current FY 2026-12-31	$-13.50	$-13.50	$-13.50	—	-11.1%	1↑ 0↓	$0.0B	-11.3%	1
Next FY 2027-12-31	$-12.00	$-12.00	$-12.00	11.1%	-300.0%	1↑ 0↓	$0.0B	3013.4%	1

Current Quarter EPS Revision History

Timepoint	EPS Estimate	Change
Current	$-3.000
7d ago	$-3.000
30d ago	$-3.000
60d ago	$-3.000
90d ago	$-3.000

4 analyst firms have rated this stock: 1 upgrades, 4 downgrades, 4 initiations.

Historical Analyst Actions

Date	Analyst Firm	Action	Previous Rating	New Rating
Nov 26, 2025	Maxim Group	INITIATE	—	Buy
Nov 24, 2025	HC Wainwright & Co.	REITERATE	Neutral	Neutral
Oct 28, 2025	D. Boral Capital	MAINTAIN	Buy	Buy
Oct 16, 2025	D. Boral Capital	MAINTAIN	Buy	Buy
Sep 19, 2025	D. Boral Capital	MAINTAIN	Buy	Buy
Sep 17, 2025	D. Boral Capital	MAINTAIN	Buy	Buy
Aug 15, 2025	D. Boral Capital	MAINTAIN	Buy	Buy
Apr 28, 2025	D. Boral Capital	INITIATE	—	Buy
Mar 28, 2025	HC Wainwright & Co.	MAINTAIN	Neutral	Neutral
Nov 11, 2024	HC Wainwright & Co.	REITERATE	Neutral	Neutral
Aug 12, 2024	HC Wainwright & Co.	MAINTAIN	Neutral	Neutral
Jun 17, 2024	HC Wainwright & Co.	REITERATE	Neutral	Neutral
May 13, 2024	HC Wainwright & Co.	MAINTAIN	Neutral	Neutral
Mar 15, 2024	HC Wainwright & Co.	MAINTAIN	Neutral	Neutral
Dec 29, 2023	HC Wainwright & Co.	REITERATE	Neutral	Neutral
Nov 13, 2023	HC Wainwright & Co.	MAINTAIN	Neutral	Neutral
Aug 14, 2023	HC Wainwright & Co.	MAINTAIN	Neutral	Neutral
May 15, 2023	HC Wainwright & Co.	REITERATE	Neutral	Neutral
Mar 20, 2023	HC Wainwright & Co.	DOWNGRADE	Buy	Neutral
Feb 23, 2023	HC Wainwright & Co.	REITERATE	—	Buy
Nov 14, 2022	HC Wainwright & Co.	MAINTAIN	—	Buy
Aug 15, 2022	HC Wainwright & Co.	MAINTAIN	—	Buy
Aug 12, 2022	Sidoti & Co.	DOWNGRADE	Buy	Neutral
May 16, 2022	HC Wainwright & Co.	MAINTAIN	—	Buy
Nov 12, 2021	HC Wainwright & Co.	MAINTAIN	—	Buy
Mar 29, 2021	Maxim Group	DOWNGRADE	Buy	Hold
Mar 26, 2021	HC Wainwright & Co.	MAINTAIN	—	Buy
Dec 15, 2020	HC Wainwright & Co.	MAINTAIN	—	Buy
Nov 17, 2020	HC Wainwright & Co.	MAINTAIN	—	Buy
Aug 14, 2020	HC Wainwright & Co.	MAINTAIN	—	Buy
May 20, 2020	Maxim Group	UPGRADE	Hold	Buy
May 18, 2020	HC Wainwright & Co.	REITERATE	—	Buy
Mar 3, 2020	Maxim Group	DOWNGRADE	Buy	Hold
Feb 24, 2020	HC Wainwright & Co.	MAINTAIN	—	Buy
Apr 9, 2019	Maxim Group	INITIATE	—	Buy
Mar 11, 2019	HC Wainwright & Co.	INITIATE	—	Buy

Monthly Consensus History

Period	Strong Buy	Buy	Hold	Sell	Strong Sell	Buy %
Jun 1, 2026	0	0	4	1	2	0%
May 1, 2026	0	0	4	1	2	0%
Apr 1, 2026	0	0	4	1	2	0%
Mar 1, 2026	0	0	4	1	2	0%
Feb 1, 2026	0	0	4	1	2	0%
Jan 1, 2026	2	4	2	0	0	75%

Strong BuyBuyHoldSellStrong Sell

∅

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

50°

Neutral

Bearish Neutral Bullish

10 mentions 4 bullish 4 bearish 10 time periods

Reddit Sentiment History

Date	Mentions	Sentiment	Bullish	Bearish	Threads
Jun 2, 2026	1	40° Cool	0	1	1
Jun 2, 2026	1	40° Cool	0	1	1
May 29, 2026	1	56° Neutral	0	0	1
May 29, 2026	1	56° Neutral	0	0	1
May 22, 2026	1	60° Warm	1	0	1
May 22, 2026	1	60° Warm	1	0	1
May 19, 2026	1	40° Cool	0	1	1
May 19, 2026	1	40° Cool	0	1	1
Apr 20, 2026	1	60° Warm	1	0	1
Apr 20, 2026	1	60° Warm	1	0	1

Recent Reddit Threads

r/pennystocks Bearish 19d 1h ago

$DYAI $0.78 Low Float Play Tied to HANTAVIRUS, EBOLA & Rapid Vaccine Development

▲ 1 💬 0 ⚡ 0.5

r/pennystocks Neutral 22d 12h ago

$CODX profit short! Did anyone catch it?

▲ 1 💬 0 ⚡ 0.5

r/pennystocks Bullish 23d 21h ago

🚨 Ebola Virus Alert 🌍 As global health concerns rise again, biotech and diagnostic companies could see major attention from investors. 📈 Keeping an eye on:✅ CODX✅ SNGX

▲ 1 💬 0 ⚡ 0.5

r/pennystocks Bullish 23d 21h ago

🚨 Ebola Virus Alert 🌍 As global health concerns rise again, biotech and diagnostic companies could see major attention from investors. 📈 Keeping an eye on:✅ CODX✅ SNGX

▲ 1 💬 1 ⚡ 0.5

r/stocks Bullish 29d 14h ago

CODX a good option for high-risk/reward stock?

▲ 1 💬 0 ⚡ 0.5

r/pennystocks Bearish 1mo ago

$CODX +17% — Ebola outbreak diagnostic assay play

▲ 1 💬 1 ⚡ 0.5

r/pennystocks Bullish 2mo ago

$CODX Curling Off the Lows...Is a Major TB Catalyst About to Ignite This Micro‑Cap?

▲ 1 💬 1 ⚡ 0.5

Jun 4, 2026

short_volume

Short Volume: CODX — 58.2% short (0.7M / 1.1M)

Short: 660,242 | Exempt: 202,106 | TRF Vol: 1,133,839 | Short Ratio: 58.2% | Off-exchange volume (dark pool + OTC)

Jun 2, 2026

short_volume

Short Volume: CODX — 56.3% short (1.2M / 2.2M)

Short: 1,227,658 | Exempt: 263,629 | TRF Vol: 2,182,153 | Short Ratio: 56.3% | Off-exchange volume (dark pool + OTC)

Jun 1, 2026

short_volume

Short Volume: CODX — 61.8% short (0.7M / 1.1M)

Short: 650,885 | Exempt: 242,658 | TRF Vol: 1,053,056 | Short Ratio: 61.8% | Off-exchange volume (dark pool + OTC)

May 28, 2026

ftd

FTD: CODX — 160,063 shares ($1.2M) failed to deliver

Settlement: 20260528, Price: $7.30, FTD Value: $1,168,459.9, CO-DIAGNOSTICS INC COM NEW

May 27, 2026

ftd

FTD: CODX — 265,439 shares ($2.4M) failed to deliver

Settlement: 20260527, Price: $9.11, FTD Value: $2,418,149.29, CO-DIAGNOSTICS INC COM NEW

May 22, 2026

ftd

FTD: CODX — 690,949 shares ($2.6M) failed to deliver

Settlement: 20260522, Price: $3.71, FTD Value: $2,563,420.79, CO-DIAGNOSTICS INC COM NEW

May 20, 2026

ftd

FTD: CODX — 1,326,249 shares ($2.6M) failed to deliver

Settlement: 20260520, Price: $1.97, FTD Value: $2,612,710.53, CO-DIAGNOSTICS INC COM NEW

May 19, 2026

short_volume

Short Volume: CODX — 56.5% short (29.4M / 51.9M)

Short: 29,358,354 | Exempt: 227,823 | TRF Vol: 51,930,845 | Short Ratio: 56.5% | Off-exchange volume (dark pool + OTC)

May 14, 2026

earnings_calendar

CODX Q1 2026 Earnings Scheduled — 2026-05-14

May 6, 2026

earnings_calendar

CODX Q1 2026 Earnings Scheduled — 2026-05-06

Mar 25, 2026

short_volume

Short Volume: CODX — 56.7% short (0.4M / 0.8M)

Short: 441,395 | Exempt: 51,606 | TRF Vol: 778,873 | Short Ratio: 56.7% | Off-exchange volume (dark pool + OTC)

Mar 23, 2026

short_interest

FTD: CODX — 332,408 shares ($0.9M) failed to deliver

Settlement: 20260323, Price: $2.59, FTD Value: $860,936.72, CO-DIAGNOSTICS INC COM NEW

Mar 19, 2026

earnings_calendar

CODX Q4 2025 Earnings After Market Close — 2026-03-19